Skip to content

Clinical study on the treatment of allergic rhinitis by combining ganglion with traditional acupoint catgut embedding

Clinical study on the treatment of allergic rhinitis by combining ganglion with traditional acupoint catgut embedding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000109
Enrollment
Unknown
Registered
2025-01-14
Start date
2022-11-10
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Drug control group:Take oral levocetirizine 10mg once daily for 3 consecutive days
Butterfly Palate Ganglion combined with traditional acupoint catgut embedding group:After embedding threads in the sphenopalatine ganglion thread embedding is performed at the Yingxiang Feishu and Din
Coccygeal ganglion embedding group:Implanting threads at the sphenopalatine ganglion area
Traditional Acupoint Embedding Group:Thread embedding therapy at Yingxiang Feishu and Dingchuan acupoints

Sponsors

The Second Hospital of Yulin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Those who meet the AR diagnostic criteria; 2) Without other comorbidities; 3) Aged 18 to 60 years old; 4) Good compliance willing to join the study abide by the requirements of this study and can adhere to follow-up.

Exclusion criteria

Exclusion criteria: 1) Patients currently receiving medication desensitization treatment or any other treatment that may affect the efficacy; 2) Patients with other severe nasal diseases such as sinusitis or those with significant nasal septum deviation; 3) Patients with severe cardiovascular or cerebrovascular diseases immunodeficiency liver or kidney function impairment or those with malignant tumors; 4) Pregnant women.

Design outcomes

Primary

MeasureTime frame
Allergic Rhinitis Symptoms and Signs Scoring;

Secondary

MeasureTime frame
Specific IgE testing;rhino conjunctivitis quslity of life questionnaire. RQLQ;Blood Regular Testing;

Countries

China

Contacts

Public ContactGuangyong Du

The Second Hospital of Yulin

389130599@qq.com15309126116

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026